Results 221 to 230 of about 595,021 (365)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Artificial Intelligence in Assisted Reproductive Technology: A New Era in Fertility Treatment. [PDF]

Cureus
Orovou E, Tzimourta KD, Tzitiridou-Chatzopoulou M, Kakatosi A, Sarantaki A.   +4 more
europepmc   +1 more source

Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (OvidrelR) to urinary hCG (ProfasiR) for induction of final follicular maturation in in vitro fertilization–embryo transfer [PDF]

, 2001
Peter L. Chang, Susan Kenley, Tammy L. Burns, Geoff Denton, Karen Currie, Gary W. DeVane, Louis O’Dea   +6 more
openalex   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology. [PDF]

Int J Biol Sci
Guo Z, Zhu Z, Lin X, Zhang KM, Wu Q, Wang S, Luo M, Lin X, Wang L, Zhou J.   +9 more
europepmc   +1 more source

Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility [PDF]

, 2001
Dana A. Ohl, Lynda Wolf, Alan C. Menge, Gregory M. Christman, William W. Hurd, Rudi Ansbacher, Yolanda R. Smith, John F. Randolph   +7 more
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Impact of paternal hepatitis B on pregnancy outcomes in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis. [PDF]

PeerJ
Gao J, Dong Q, Shen L, Zhu X.
europepmc   +1 more source

The future of international registries for assisted reproductive technologies [PDF]

, 2001
Jean Cohen
openalex   +1 more source

Synthetic Cells, Synthetic Life, and Inheritance [PDF]

, 2011
Knapland, Kristine S.
core   +1 more source